On Tuesday, a U.S. Senate Subcommittee will hold a hearing on a bill from Vermont Senator Bernie Sanders that would use an Open Innovation prize model to push forward the development of more effective and affordable drugs to treat HIV/AIDS.
The bill S. 1138 would "eliminate legal barriers to generic competition for HIV/AIDS drugs and reward innovation directly, through a $3 billion a year prize fund," according to a statement from the Senator's office.
To read the full, original article click on this link: U.S. Senator Looks to Open Innovation to Create Cheaper HIV/AIDS Drugs
